50% more effective than current gold standard
Unmatched cost saving potential
No bleb related complications
A breakthrough in glaucoma implants
Re-defining the
treatment of glaucoma
of the global adult population affected
2%
of patients will progress to blindness
42%
the direct cost of glaucoma care
$13 B
Awards
Supported by
Featured
Winner
Runner up
Winner